Results 291 to 300 of about 163,785 (367)

A web-based dynamic nomogram for predicting readmission in patients with heart failure with preserved ejection fraction. [PDF]

Front Cardiovasc Med
Ji Y, Wang G, Hu Y, Wang X, Wu W, Luo Y, Pan Y, Liu J, Li L, Zhu H, Pan D.   +10 more
europepmc   +1 more source

Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1492-1493, April 2025.
Umut Kocabas
wiley   +1 more source

Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device

ESC Heart Failure, EarlyView.
Abstract Aims Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD‐HT compared with donation after brain death (DBD) HT in LVAD patients. Methods
Aris Karatasakis, Edwin Grajeda Silvestri, Gatha G. Nair, Benjamin Zuniga, Song Li, Claudius Mahr, Richard K. Cheng, April S. Stempien‐Otero, Ioannis Dimarakis, Maziar Khorsandi, Jay D. Pal, Jorge R. Kizer, Marc A. Simon, Claudio A. Bravo   +13 more
wiley   +1 more source

Contemporary Prevalence and Correlates of Incident Heart Failure with Preserved Ejection Fraction

, 2013
Jerry H. Gurwitz, David J. Magid, David H. Smith, Robert J. Goldberg, David D. McManus, Larry A. Allen, Jane S. Saczynski, Micah L. Thorp, Grace Hsu, Sue Hee Sung, Alan S. Go   +10 more
openalex   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA‐HF trial

ESC Heart Failure, EarlyView.
Graphical presentation of the study design, main results and conclusion. Abbreviations: Y/O = year old; HFpEF = heart failure with preserved ejection fraction; Kg = kilograms; NYHA = New York Heart Association; ACE = angiotensin‐converting enzyme; ARB = angiotensin receptor blockers; ARNI = angiotensin receptor‐neprilysin inhibitor; SGLT2i = sodium ...
Amit Gruber, Aharon (Ronnie) Abbo, Ina Volis, Doron Aronson, Nicolas Girerd, Søren Lund Kristensen, Robert Zukermann, Natalia Alberkant, Elena Sitnitsky, Anton Kruger, Polina Khasis, Evgeny Bravo, Boaz Elad, Ludmila Helmer Levin, Oren Caspi   +14 more
wiley   +1 more source

Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. [PDF]

Cardiovasc Diabetol
Weerts J, Schroen BLM, Barandiarán Aizpurua A, Berendschot TTJM, Brandts L, Webers CAB, Simons SO, Meex SJR, Henry R, van der Kallen CJH, Brunner-La Rocca HP, Knackstedt C, Heymans SRB, de Boer RA, van Empel VPM, Houben AJHM.   +15 more
europepmc   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

ESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo   +8 more
wiley   +1 more source

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure With Preserved Ejection Fraction: A Systematic Review. [PDF]

Cureus
Saeed A, Younas B, Rohan A, Haider U, Mukhtar A, Nazir M, Maryam.   +6 more
europepmc   +1 more source

Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia, Daniëlle M. Coenen, Titus P. Lemmens, Lloyd Brandts, Simone J. H. Wielders, Magdolna Nagy, Sanne G. J. Mourmans, Anouk Achten, Ahmad Al‐Abadi, Jerremy Weerts, Arantxa Barandiaran Aizpurua, Vanessa van Empel, Blanche Schroen, Judith M. E. M. Cosemans   +13 more
wiley   +1 more source